Lexology November 7, 2022
Crowell & Moring LLP

President Biden signs Executive Order directing HHS to “consider additional actions to further drive down prescription drug costs”

On October 14, 2022, President Biden signed an Executive Order (EO) directing the Secretary of the Department of Health and Human Services (HHS) to consider new healthcare payment and delivery models the Center for Medicare & Medicaid Innovation (CMMI), part of the Centers for Medicare & Medicaid Services (CMS) and created by the Affordable Care Act, can test to lower drug costs and promote access to innovative drug therapies for Medicare and Medicaid beneficiaries. The EO specifies the HHS Secretary should include models that may lead to lower cost-sharing for commonly used drugs and support value-based payment initiatives that promote high-quality care....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Payment Models, Pharma, Pharma / Biotech, Value Based
How extending virtual options can drive value-based care
Health system C-suites eye value-based care roles
Incentivizing Provider Engagement for Improved Value-Based Outcomes
201: Value series: What does health system VBC adoption actually look like?
Creating a Roadmap to Value-Based Care in Autism

Share This Article